Management of Parkinson's Disease

Medication Considerations

• Cholinesterase inhibitors like rivastigmine may help alleviate psychosis in Parkinson's disease patients with cognitive decline, according to the American Academy of Sleep Medicine 1
• The American Society of Clinical Oncology recommends avoiding all typical antipsychotics, including prochlorperazine, haloperidol, and chlorpromazine, in Parkinson's disease patients 2

Treatment Approach

• For patients with psychosis, rivastigmine may be considered, especially those with concurrent cognitive decline, as suggested by the American Academy of Sleep Medicine 1